| 000 | 01429 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250511224241.0 | ||
| 264 | 0 | _c19910306 | |
| 008 | 199103s 0 0 eng d | ||
| 022 | _a0959-8049 | ||
| 024 | 7 |
_a10.1016/0277-5379(90)90053-v _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCebon, J S | |
| 245 | 0 | 0 |
_aThe effects of dose and route of administration on the pharmacokinetics of granulocyte-macrophage colony-stimulating factor. _h[electronic resource] |
| 260 |
_bEuropean journal of cancer (Oxford, England : 1990) _c1990 |
||
| 300 |
_a1064-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Evaluation |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGranulocyte-Macrophage Colony-Stimulating Factor _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 | _aInjections, Subcutaneous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 700 | 1 | _aBury, R W | |
| 700 | 1 | _aLieschke, G J | |
| 700 | 1 | _aMorstyn, G | |
| 773 | 0 |
_tEuropean journal of cancer (Oxford, England : 1990) _gvol. 26 _gno. 10 _gp. 1064-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0277-5379(90)90053-v _zAvailable from publisher's website |
| 999 |
_c2155027 _d2155027 |
||